| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
|
N Engl J Med
|
2015
|
5.71
|
|
2
|
The P4-type ATPase ATP11C is essential for B lymphopoiesis in adult bone marrow.
|
Nat Immunol
|
2011
|
1.96
|
|
3
|
Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center.
|
Am J Surg Pathol
|
2013
|
1.84
|
|
4
|
Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells.
|
Proc Natl Acad Sci U S A
|
2007
|
1.80
|
|
5
|
Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis.
|
Mod Pathol
|
2006
|
1.64
|
|
6
|
Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies.
|
Cancer Cell
|
2006
|
1.58
|
|
7
|
Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma.
|
Blood
|
2012
|
1.58
|
|
8
|
Rapid identification of a disease allele in mouse through whole genome sequencing and bulk segregation analysis.
|
Genetics
|
2010
|
1.56
|
|
9
|
Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells.
|
Proc Natl Acad Sci U S A
|
2010
|
1.55
|
|
10
|
B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
|
Mod Pathol
|
2011
|
1.49
|
|
11
|
Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis.
|
Cancer Cell
|
2007
|
1.45
|
|
12
|
Double hit lymphoma: the MD Anderson Cancer Center clinical experience.
|
Br J Haematol
|
2014
|
1.43
|
|
13
|
A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma.
|
Clin Cancer Res
|
2008
|
1.29
|
|
14
|
Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia.
|
Am J Clin Pathol
|
2005
|
1.24
|
|
15
|
NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses.
|
Blood
|
2005
|
1.19
|
|
16
|
High-grade B-cell lymphoma/leukemia associated with t(14;18) and 8q24/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis.
|
Haematologica
|
2007
|
1.18
|
|
17
|
Extranodal lymphomas of the head and neck.
|
Ann Diagn Pathol
|
2005
|
1.15
|
|
18
|
Bulk segregation mapping of mutations in closely related strains of mice.
|
Genetics
|
2010
|
1.15
|
|
19
|
Three-dimensional ordered ZnO/Cu2O nanoheterojunctions for efficient metal-oxide solar cells.
|
ACS Appl Mater Interfaces
|
2015
|
1.12
|
|
20
|
Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
|
Clin Cancer Res
|
2005
|
1.08
|
|
21
|
Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation.
|
Blood Coagul Fibrinolysis
|
2003
|
1.07
|
|
22
|
Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type.
|
Br J Haematol
|
2005
|
1.07
|
|
23
|
Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.
|
J Clin Pathol
|
2012
|
1.06
|
|
24
|
Mobilization of CD34+ cells in elderly patients (>/= 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen.
|
Br J Haematol
|
2003
|
1.06
|
|
25
|
Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations.
|
Am J Clin Pathol
|
2004
|
1.04
|
|
26
|
Marginal zone lymphomas with plasmacytic differentiation and related disorders.
|
Am J Clin Pathol
|
2011
|
1.03
|
|
27
|
CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases.
|
Hum Pathol
|
2012
|
1.03
|
|
28
|
p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction.
|
Cancer Res
|
2012
|
1.02
|
|
29
|
Myeloid sarcoma involving the testis.
|
Am J Clin Pathol
|
2005
|
1.00
|
|
30
|
A role for PML3 in centrosome duplication and genome stability.
|
Mol Cell
|
2005
|
0.98
|
|
31
|
Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma.
|
Mod Pathol
|
2006
|
0.97
|
|
32
|
Residual monotypic plasma cells in patients with waldenstrom macroglobulinemia after therapy.
|
Am J Clin Pathol
|
2011
|
0.96
|
|
33
|
Advances in the molecular pathobiology of B-lymphoblastic leukemia.
|
Hum Pathol
|
2012
|
0.95
|
|
34
|
Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de novo acute myeloid leukemia with t(8;21)(q22;q22) but does not have a favorable outcome.
|
Am J Clin Pathol
|
2009
|
0.94
|
|
35
|
Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein.
|
Am J Clin Pathol
|
2005
|
0.93
|
|
36
|
Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?
|
Haematologica
|
2011
|
0.92
|
|
37
|
Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases.
|
Am J Surg Pathol
|
2013
|
0.91
|
|
38
|
MYC/BCL2 double-hit high-grade B-cell lymphoma.
|
Adv Anat Pathol
|
2013
|
0.91
|
|
39
|
t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia.
|
Am J Clin Pathol
|
2004
|
0.91
|
|
40
|
CD117, but not lysozyme, is positive in cutaneous plasmacytoma.
|
Arch Pathol Lab Med
|
2003
|
0.91
|
|
41
|
Expression of B cell-specific activator protein/PAX5 in acute myeloid leukemia with t(8;21)(q22;q22).
|
Am J Clin Pathol
|
2006
|
0.90
|
|
42
|
Expression of heat-shock protein-90 in non-Hodgkin's lymphomas.
|
Mod Pathol
|
2005
|
0.89
|
|
43
|
Rosai-Dorfman disease confined to the breast.
|
Ann Diagn Pathol
|
2010
|
0.89
|
|
44
|
Potential therapeutic biomarkers in plasma cell myeloma: a flow cytometry study.
|
Cytometry B Clin Cytom
|
2013
|
0.89
|
|
45
|
Postsplenectomy cytomegaloviral mononucleosis: marked lymphocytosis, TCRgamma gene rearrangements, and impaired IgM response.
|
Am J Clin Pathol
|
2005
|
0.87
|
|
46
|
Flow cytometric immunophenotyping of anaplastic large cell lymphoma.
|
Arch Pathol Lab Med
|
2009
|
0.87
|
|
47
|
Aberrant EVI1 expression in acute myeloid leukemias associated with the t(3;8)(q26;q24).
|
Cancer Genet Cytogenet
|
2007
|
0.87
|
|
48
|
Plasmablastic lymphoma involving the penis: a previously unreported location of a case with aberrant CD3 expression.
|
Pathology
|
2011
|
0.87
|
|
49
|
MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma.
|
Am J Surg Pathol
|
2015
|
0.87
|
|
50
|
Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome.
|
Am J Clin Pathol
|
2012
|
0.87
|
|
51
|
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.
|
Haematologica
|
2014
|
0.86
|
|
52
|
The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype.
|
Leuk Res
|
2003
|
0.86
|
|
53
|
Bone marrow transplant engraftment analysis with loss of an informative allele.
|
J Mol Diagn
|
2002
|
0.85
|
|
54
|
The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders.
|
Mod Pathol
|
2007
|
0.85
|
|
55
|
De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification.
|
Mod Pathol
|
2010
|
0.85
|
|
56
|
c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders.
|
Am J Surg Pathol
|
2007
|
0.85
|
|
57
|
Myeloid sarcoma of the urinary bladder and epididymis as a primary manifestation of acute myeloid leukemia with inv(16).
|
Arch Pathol Lab Med
|
2006
|
0.84
|
|
58
|
Piezotronic interface engineering on ZnO/Au-based Schottky junction for enhanced photoresponse of a flexible self-powered UV detector.
|
ACS Appl Mater Interfaces
|
2014
|
0.84
|
|
59
|
Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
|
Cancer
|
2007
|
0.83
|
|
60
|
inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases.
|
Am J Clin Pathol
|
2005
|
0.83
|
|
61
|
Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma.
|
Mod Pathol
|
2013
|
0.83
|
|
62
|
Acute lymphoblastic leukemia arising in post-polycythemic myelofibrosis: a rare entity.
|
Leuk Lymphoma
|
2012
|
0.83
|
|
63
|
Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation.
|
Ann Diagn Pathol
|
2006
|
0.83
|
|
64
|
High-grade B cell lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and/or MYC gene rearrangements and a poor prognosis.
|
Histopathology
|
2012
|
0.82
|
|
65
|
Usefulness of flow cytometric immunophenotyping for bone marrow staging in patients with mantle cell lymphoma after therapy.
|
Am J Clin Pathol
|
2012
|
0.82
|
|
66
|
Bacterial artificial chromosome array-based comparative genomic hybridization using paired formalin-fixed, paraffin-embedded and fresh frozen tissue specimens in multiple myeloma.
|
Cancer
|
2009
|
0.82
|
|
67
|
Expression of serine 194-phosphorylated Fas-associated death domain protein correlates with proliferation in B-cell non-Hodgkin lymphomas.
|
Hum Pathol
|
2011
|
0.82
|
|
68
|
Examining Hedgehog pathway genes GLI3, SHH, and PTCH1 and the p53 target GLIPR1/GLIPR1L1/GLIPR1L2 gene cluster using fluorescence in situ hybridization uncovers GLIPR1/GLIPR1L1/GLIPR1L2 deletion in 9% of patients with multiple myeloma.
|
J Assoc Genet Technol
|
2010
|
0.82
|
|
69
|
The utility of interphase fluorescence in situ hybridization for the detection of the translocation t(11;14)(q13;q32) in the diagnosis of mantle cell lymphoma on fine-needle aspiration specimens.
|
Cancer
|
2005
|
0.82
|
|
70
|
Clonal relationship of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue involving different sites.
|
Am J Clin Pathol
|
2010
|
0.81
|
|
71
|
Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study.
|
Hum Pathol
|
2012
|
0.81
|
|
72
|
CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T/myeloid acute leukemia.
|
Am J Clin Pathol
|
2012
|
0.81
|
|
73
|
The oncofetal protein IMP3: a novel molecular marker to predict aggressive meningioma.
|
Arch Pathol Lab Med
|
2011
|
0.81
|
|
74
|
Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia.
|
Am J Clin Pathol
|
2005
|
0.81
|
|
75
|
Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia.
|
Am J Clin Pathol
|
2011
|
0.81
|
|
76
|
Dynamic balance of multiple myeloma clonogenic side population cell percentages controlled by environmental conditions.
|
Int J Cancer
|
2014
|
0.80
|
|
77
|
High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
|
Am J Surg Pathol
|
2016
|
0.80
|
|
78
|
Follicular lymphoma in staging bone marrow specimens: correlation of histologic findings with the results of flow cytometry immunophenotypic analysis.
|
Arch Pathol Lab Med
|
2007
|
0.79
|
|
79
|
Primary autoimmune myelofibrosis (MF) with high-grade peripheral T-cell lymphoma (PTCL) NOS.
|
Eur J Haematol
|
2013
|
0.79
|
|
80
|
In situ transmission electron microscopy investigation on fatigue behavior of single ZnO wires under high-cycle strain.
|
Nano Lett
|
2014
|
0.79
|
|
81
|
Metastatic splenic angiosarcoma presenting with thrombocytopenia and bone marrow fibrosis mimicking idiopathic thrombocytopenic purpura and primary myelofibrosis: a diagnostic challenge.
|
Clin Lymphoma Myeloma Leuk
|
2013
|
0.78
|
|
82
|
Bone marrow stromal cells derived MCP-1 reverses the inhibitory effects of multiple myeloma cells on osteoclastogenesis by upregulating the RANK expression.
|
PLoS One
|
2013
|
0.78
|
|
83
|
Chronic myeloproliferative diseases with the t(5;12)(q33;p13): clonal evolution is associated with blast crisis.
|
Am J Clin Pathol
|
2006
|
0.78
|
|
84
|
Janus kinase 2 V617F mutation is detectable in spleen of patients with chronic myeloproliferative diseases suggesting a malignant nature of splenic extramedullary hematopoiesis.
|
Hum Pathol
|
2007
|
0.78
|
|
85
|
Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and does not correlate with p65 NF-kappaB activation.
|
Mod Pathol
|
2006
|
0.77
|
|
86
|
Waldenström macroglobulinemia: a review of the entity and its differential diagnosis.
|
Adv Anat Pathol
|
2012
|
0.77
|
|
87
|
Acute myeloid leukemia associated with variant t(8;21) detected by conventional cytogenetic and molecular studies: a report of four cases and review of the literature.
|
Am J Clin Pathol
|
2006
|
0.77
|
|
88
|
CXC chemokine receptor 4 expression, CXC chemokine receptor 4 activation, and wild-type nucleophosmin are independently associated with unfavorable prognosis in patients with acute myeloid leukemia.
|
Clin Lymphoma Myeloma Leuk
|
2013
|
0.76
|
|
89
|
Myelodysplastic syndromes should been renamed as myelodysplastic neoplasms.
|
Leuk Res
|
2013
|
0.75
|
|
90
|
Aberrant myeloid maturation identified by flow cytometry in primary myelofibrosis.
|
Am J Clin Pathol
|
2010
|
0.75
|
|
91
|
Immunohistochemical profile and fluorescence in situ hybridization analysis of diffuse large B-cell lymphoma in northern China.
|
Arch Pathol Lab Med
|
2010
|
0.75
|
|
92
|
Bovine serum albumin in the preparation of peripheral blood smears.
|
Cytometry B Clin Cytom
|
2004
|
0.75
|
|
93
|
Enhanced performance of ZnO piezotronic pressure sensor through electron-tunneling modulation of MgO nanolayer.
|
ACS Appl Mater Interfaces
|
2015
|
0.75
|
|
94
|
[Solute transport modeling application in groundwater organic contaminant source identification].
|
Huan Jing Ke Xue
|
2012
|
0.75
|
|
95
|
Investigation on the mechanism of nanodamage and nanofailure for single ZnO nanowires under an electric field.
|
ACS Appl Mater Interfaces
|
2014
|
0.75
|
|
96
|
Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
|
Hum Pathol
|
2012
|
0.75
|
|
97
|
Introduction to multiple myeloma special issue: The flow cytometric detection of minimal residual disease.
|
Cytometry B Clin Cytom
|
2016
|
0.75
|
|
98
|
[Differential gene expression profiling for identification of protective transcription factors in different subtypes of nasopharyngeal carcinoma].
|
Nan Fang Yi Ke Da Xue Xue Bao
|
2013
|
0.75
|
|
99
|
Refractory anemia with ring sideroblasts associated with marked thrombocytosis: a mixed group exhibiting a spectrum of morphologic findings.
|
Am J Clin Pathol
|
2011
|
0.75
|
|
100
|
Design of efficient dye-sensitized solar cells with patterned ZnO-ZnS core-shell nanowire array photoanodes.
|
Nanoscale
|
2014
|
0.75
|
|
101
|
Asymmetric behavior in flexible piezoelectric strain sensors made of single ZnO nanowires.
|
J Nanosci Nanotechnol
|
2014
|
0.75
|